Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Sponsor: JW Pharmaceutical
Summary
A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia
Official title: A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
162
Start Date
2024-12-02
Completion Date
2026-04
Last Updated
2025-09-09
Healthy Volunteers
No
Conditions
Interventions
JW0104+C2402
For 8 weeks(PO (Per Oral), QD)
JW0104+C2403
For 8 weeks(PO, QD)
C2402
For 8 weeks(PO, QD)
Locations (1)
Gangdong Sacred Heart Hospital
Seoul, South Korea